Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,722 | -4,947 | -8,510 | -6,217 | -4,137 |
| Depreciation Amortization | 281 | 87 | 170 | 130 | 87 |
| Other Working Capital | -485 | 871 | 20 | -518 | -341 |
| Other Operating Activity | 1,211 | 223 | 220 | 112 | 76 |
| Operating Cash Flow | $-10,715 | $-3,766 | $-8,100 | $-6,493 | $-4,315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -905 | -195 | -380 | -326 | N/A |
| Purchase Of Investment | -16,412 | 0 | N/A | 0 | N/A |
| Investing Cash Flow | $-17,317 | $-195 | $-380 | $-326 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 78,995 | 25 | N/A | 0 | N/A |
| Other Financing Activity | 0 | 0 | 49,750 | 49,755 | 42,414 |
| Financing Cash Flow | $78,995 | $25 | $49,750 | $49,755 | $42,414 |
| Exchange Rate Effect | -36 | -12 | 20 | 42 | 45 |
| Beginning Cash Position | 51,046 | 51,046 | 9,760 | 9,760 | 9,760 |
| End Cash Position | 101,973 | 47,098 | 51,040 | 52,738 | 47,904 |
| Net Cash Flow | $50,927 | $-3,948 | $41,280 | $42,978 | $38,144 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,715 | -3,766 | -8,100 | -6,493 | -4,315 |
| Capital Expenditure | -915 | -195 | N/A | -326 | N/A |
| Free Cash Flow | -11,630 | -3,961 | -8,100 | -6,819 | -4,315 |